Viagra Research Today is a free monthly online journal that collates and summarizes the latest research about Viagra, including details on sildenafil, erectile dysfunction, impotence, side-effects, alternatives.

Volume 3 (2006), Issue 10 (October)

1. A Novel Approach Incorporating Sildenafil in the Management of Symptomatic Neonates with Ebstein's Anomaly.
   Pediatr Cardiol, 27(5): 614-7. [Abstract] [Full-text]
2. Efficacy of sildenafil citrate in treatment of erectile dysfunction: impact of associated premature ejaculation and low desire.
   Urology, 68(3): 642-7. [Abstract] [Full-text]
3. Effect of sildenafil citrate treatment on serum dehydroepiandrosterone sulfate levels in patients with erectile dysfunction.
   Urology, 68(3): 626-30. [Abstract] [Full-text]
4. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
   Urology, 68(3): 47-60. [Abstract] [Full-text]
5. A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunction.
   Urology, 68(3): 38-46. [Abstract] [Full-text]
6. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).
   Urology, 68(3): 26-37. [Abstract] [Full-text]
7. Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.
   Urology, 68(3): 17-25. [Abstract] [Full-text]
8. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation.
   Int J Androl, 29(5): 503-09. [Abstract] [Full-text]
9. Sexual health after orthotopic liver transplantation.
   Liver Transpl, 12(10): 1478-84. [Abstract] [Full-text]
10. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.
    Eur Urol, 50(5): 940-7. [Abstract] [Full-text]
11. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    BJU Int, 98(5): 979-81. [Abstract] [Full-text]
12. Pulmonary hypertension as a dominant clinical picture in a case of amyloidosis and smoldering multiple myeloma.
    Int J Cardiol. [Abstract] [Full-text]
13. Management of sildenafil treatment failures.
    Curr Opin Urol, 16(6): 449-59. [Abstract] [Full-text]
14. Pharmacologic treatment for pulmonary arterial hypertension.
    Curr Opin Cardiol, 21(6): 561-8. [Abstract] [Full-text]
15. Pulmonary arterial hypertension and women.
    Cardiol Rev, 14(6): 312-8. [Abstract] [Full-text]
16. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Mol Pharmacol, 70(5): 1822-31. [Abstract] [Full-text]
17. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children.
    Am J Respir Crit Care Med, 174(9): 1042-7. [Abstract] [Full-text]
18. Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment.
    J Urol, 176(5): 2132-7. [Abstract] [Full-text]
19. Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study.
    Int J Impot Res, 18(6): 550-8. [Abstract] [Full-text]
20. A meta-regression analysis of treatment effect modifiers in trials with flexible-dose oral sildenafil for erectile dysfunction in broad-spectrum populations.
    Int J Impot Res, 18(6): 559-65. [Abstract] [Full-text]

© 2004-2008 Viagra Research Today. All Rights Reserved.